314 related articles for article (PubMed ID: 32268883)
1. Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy.
Zarghamian P; Azarkeivan A; Arabkhazaeli A; Mardani A; Shahabi M
BMC Med Genet; 2020 Apr; 21(1):75. PubMed ID: 32268883
[TBL] [Abstract][Full Text] [Related]
2. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
3. Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant.
Parajes S; González-Quintela A; Campos J; Quinteiro C; Domínguez F; Loidi L
BMC Genet; 2010 Dec; 11():110. PubMed ID: 21143959
[TBL] [Abstract][Full Text] [Related]
4. Relation of hepcidin gene expression in blood mononuclear cells with iron overload severity among β-thalassemia major patients.
Ayatollahi H; Mousavi Nezhad SF; Talebpour A; Badiei Z; Nezami H
Mol Biol Rep; 2020 Dec; 47(12):9353-9359. PubMed ID: 33231816
[TBL] [Abstract][Full Text] [Related]
5. Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major.
Andreani M; Radio FC; Testi M; De Bernardo C; Troiano M; Majore S; Bertucci P; Polchi P; Rosati R; Grammatico P
Haematologica; 2009 Sep; 94(9):1293-6. PubMed ID: 19734422
[TBL] [Abstract][Full Text] [Related]
6. Genetic modifiers of secondary iron overload in beta thalassemia major.
Athiyarath R; George B; Abraham A; Viswabandya A; Srivastava A; Edison ES
Blood Cells Mol Dis; 2015 Mar; 54(3):242-3. PubMed ID: 25601433
[No Abstract] [Full Text] [Related]
7. Hepcidin and
Fekri K; Asle Rasouli N; Tavallai Zavareh SA; Jalil M; Moradi F; Hosseinpour M; Teimori H
Int J Hematol Oncol Stem Cell Res; 2019 Jan; 13(1):42-48. PubMed ID: 31205627
[No Abstract] [Full Text] [Related]
8. Three most common nonsynonymous UGT1A6*2 polymorphisms (Thr181Ala, Arg184Ser and Ser7Ala) and therapeutic response to deferiprone in β-thalassemia major patients.
Dadheech S; Rao AV; Shaheen U; Hussien MD; Jain S; Jyothy A; Munshi A
Gene; 2013 Dec; 531(2):301-5. PubMed ID: 24036429
[TBL] [Abstract][Full Text] [Related]
9. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload.
Hagag AA; Hamam MA; Taha OA; Hazaa SM
Infect Disord Drug Targets; 2015; 15(2):98-105. PubMed ID: 26205801
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients.
Javaheri-Kermani M; Farazmandfar T; Ajami A; Yazdani Y
Scand J Infect Dis; 2014 Oct; 46(10):693-6. PubMed ID: 25134646
[TBL] [Abstract][Full Text] [Related]
13. Time to Start Delivering Iron Chelation Therapy in Newly Diagnosed Severe
Susanah S; Idjradinata PS; Sari NM; Rakhmilla LE; Sribudiani Y; Trisaputra JO; Moestopo O
Biomed Res Int; 2020; 2020():8185016. PubMed ID: 33415156
[TBL] [Abstract][Full Text] [Related]
14. Peripheral expression of hepcidin gene in Egyptian β-thalassemia major.
Aboul-Enein A; El-Beshlawy A; Hamdy M; Shaheen I; El-Saadany Z; Samir A; El-Samie HA
Gene; 2015 Jun; 564(2):206-9. PubMed ID: 25816754
[TBL] [Abstract][Full Text] [Related]
15. Determination of mutations in iron regulating genes of beta thalassemia major patients of Khyber Pakhtunkhwa, Pakistan.
Shah M; Danish L; Khan NU; Zaman F; Ismail M; Hussain M; Pervaiz R; Iqbal A
Mol Genet Genomic Med; 2020 Sep; 8(9):e1310. PubMed ID: 32588561
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of HAMP rs10421768 gene and phenotypic expression of hepcidin; a case-control study among sickle cell anaemia patients in Ghana.
Appiah SK; Nkansah C; Abbam G; Osei-Boakye F; Mensah K; Bani SB; Chemogo S; Sarpong L; Addae TG; Sefa DB; Croffien RA; Adom L; Rauf ROA; Boadu F; Amoah GA; Chukwurah EF
PLoS One; 2024; 19(6):e0306194. PubMed ID: 38935685
[TBL] [Abstract][Full Text] [Related]
17. Frequency of the HAMP (c.-582 A>G) Polymorphism in Iron Deficiency in Saudi Arabia.
Al-Amer O; Alsharif KF
Pak J Biol Sci; 2021 Jan; 24(1):146-150. PubMed ID: 33683041
[TBL] [Abstract][Full Text] [Related]
18. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.
Al-Hakeim HK; Al-Khakani MM; Al-Kindi MA
Adv Clin Exp Med; 2015; 24(1):69-78. PubMed ID: 25923089
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Growth Differentiation Factor 15 Gene Expression by Curcumin in Patients with Beta-Thalassemia Intermedia.
Saeidnia M; Ghaderi A; Erfani M; Nowrouzi-Sohrabi P; Shokri M; Tamaddon G; Karimi M; Babashahi M
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213217
[TBL] [Abstract][Full Text] [Related]
20. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
Jones E; Pasricha SR; Allen A; Evans P; Fisher CA; Wray K; Premawardhena A; Bandara D; Perera A; Webster C; Sturges P; Olivieri NF; St Pierre T; Armitage AE; Porter JB; Weatherall DJ; Drakesmith H
Blood; 2015 Jan; 125(5):873-80. PubMed ID: 25519750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
